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A BST R AC T   
 
Aim:  To construct a perfusion circuit for experimental open hyperthermic intraperitoneal perfusion (HIPEP) 
and to evaluate the antitumor effects of regional hyperthermia in a model of advanced syngeneic high-grade 
ovarian carcinoma in vivo. 
Method: 24 mature female Wistar rats underwent intraperitoneal transplantation of ascitic ovarian tumor 
1×107 cells per rat. 48 hours after transplantation the animals were randomized into two groups: I. NIPEP 
group (12 rats) – normothermic intraperitoneal perfusion (NIPEP) with normal saline at room temperature 
during 45 minutes; II. HIPEP group (12 rats) – open hyperthermic intraperitoneal perfusion (HIPEP) with 
normal saline (40.5-41.5 ℃) during 45 minutes. Endpoints included overall survival (OS), the total peritoneal 
cancer index (PCI), ascites weight and the grade of ascites hemorrhage. 
Results: In both groups all animals survived the procedure, in the HIPEP group one rat died due to infectious 
complications on day 32. Compared with NIPEP group HIPEP with normal saline significantly increased the 
median OS from 19 to 39 days (log-rank test, P=0.0013), reducing the risk of death by 68% (HR=0.32; 95% 
CI 0.13-0.82). The open HIPEP without a cytostatic was associated with significantly lower total PCI (14 vs 5 
points, P=0.0155). In the HIPEP group 3 of 12 animals had intrathoracic tumor spread with malignant pleural 
effusion without signs of peritoneal carcinomatosis and ascites. 
Conclusion: The transplanted syngeneic tumor is a valid model that allows to quantitatively assess antitumor 
activity of intraperitoneal perfusion therapy. Our preclinical data confirmed the role of regional hyperthermia 
in the treatment of peritoneal carcinomatosis in ovarian tumors. 
 
Key words: Ovarian cancer, peritoneal carcinomatosis, hyperthermia, peritoneal cancer index, HIPEC, 
preclinical study. 
                                                                                                                               
       Dr. Iaroslav Gennadevich Murazov,  
Scientific Laboratory of Cancer Chemoprevention and 
Oncopharmacology, FSBI «N.N. Petrov National 
Medical Research Center of Oncology» of the Ministry 
of Healthcare of the Russian Federation, Saint-
Petersburg, Russian Federation, 68, Leningradskaya 
str., Pesochniy Settlement, Saint-Petersburg, 197758, 
Russian Federation.  
E-mail: yaroslav84@yandex.ru 
 
Received: 2021-04-07 / Revisions: 2021-04-21 
Accepted: 2021-04-23 / Published online: 2021-07-01 
 
 Experimental Biomedical Research                                                   Original article 
                                              Murazov et al / Exp Biomed Res. 2021; 4(3):164-174 





Peritoneal surface malignancy may occur as a 
primary disease or as a metastatic tumor 
originating most often from gastrointestinal 
tract and gynecological cancers. Peritoneal 
carcinomatosis (PC) is an unfavorable 
prognostic factor associated with rapid disease 
progression, significant deterioration in the 
quality of life and high mortality of patients [1]. 
Thus, the 5-year OS of patients with epithelial 
ovarian cancer (EOC) and PC is about 29% [2]. 
Unfortunately, systemic chemotherapy has low 
efficacy against tumor deposits that have spread 
along the peritoneum, due to poor blood supply 
and the low ability of cytostatics to penetrate 
into intraperitoneal tumor nodules [3]. PC 
should be considered as a local disease that 
requires special approaches to treatment. The 
well-known synergism of the action of regional 
hyperthermia (40.5-43 ℃) and 
chemotherapeutic agents has become the reason 
for a wide study and introduction into clinical 
practice of hyperthermic intraperitoneal 
chemotherapy (HIPEC) [4]. Technically 
HIPEC can be performed using an open, closed, 
semi-open, laparoscopic technique or using an 
expander. Hyperthermia not only enhances the 
antitumor activity of cytostatics, but also has 
antitumor activity itself. The direct cytostatic 
and cytotoxic effects of supranormal 
temperatures begin at 40-41 °C, while the 
synergism between hyperthermia and 
cytostatics begins at 39 °C and decreases at 
temperature above 43 °C. Temperature above 
44 °C induce apoptosis in normal cells [3,5]. 
Currently, HIPEC is widely used in the 
treatment of PC in pseudomyxoma peritonei 
and peritoneal mesothelioma, peritoneal 
metastases of colorectal cancer. At the same 
time, for primary and recurrent EOC with PC 
the use of HIPEC is not recommended outside 
clinical trials [6,7]. This is due to the lack of 
standardization of the HIPEC procedure 
(technique, antineoplastic drugs and their 
doses, carrier solutions, optimal temperature 
and duration of perfusion, flow rate of perfusate 
etc.), as well as the absence of developed 
algorithm for managing adverse events 
associated with the procedure. Moreover, 
current clinical data failed to isolate the curative 
effects of hyperthermia itself. Until more data 
are available from evidence-based studies, it is 
reasonable to conclude that a strategy of 
surgical cytoreduction and HIPEC is rational 
and interesting, though still an investigative 
approach in the management of advanced-stage 
epithelial ovarian cancer. 
A critical stage in the investigation and 
standardization of perfusion technologies for 
the treatment of PC are preclinical studies on 
valid models in vivo. Commonly two types of 
EOC models are used for PC development in 
rodents: (1) cell lines and patient-derived 
xenografts of human tumors; (2) syngeneic 
models. In order to obtain intraperitoneal 
dissemination, the tumor can be transplanted 
intraperitoneally or orthotopically (under the 
ovarian bursa membrane) [8]. The use of 
immunodeficient animals for transplantation of 
human xenografts does not allow studying the 
interaction of a tumor with microenvironment 
in the context of the development of an immune 
response, inflammation, vascularization, and 
interaction with stromal components. 
Syngeneic models, on the contrary, make it 
possible to study the development of the 
antitumor immune response, epithelial-stromal 
interactions, and tumor vascularization. The use 
of immunocompetent animals provides a low 
incidence of infectious complications in 
comparison with immunodeficient animals. It 
should be noted that the hardware used for the 
experimental HIPEC is quite diverse. Each 
perfusion circuit is in fact a unique 
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multicomponent system [9-12]. Here we used 
an original peritoneal perfusion system, 
constructed from domestic devices. 
The aim of our study is to assess the antitumor 
effect of open hyperthermic intraperitoneal 
perfusion (HIPEP) with normal saline (40.5-
41.5℃) on the development of PC and OS in 
female Wistar rats with syngeneic high-grade 
ovarian carcinoma.  
 
Materials and methods 
Experimental design 
A single intervention proceeded 48 h after 
intraperitoneal (IP) tumor transplantation. 
Animals were randomized into two groups: I. 
NIPEP group (12 rats) – normothermic 
intraperitoneal perfusion (NIPEP) with normal 
saline at room temperature during 45 minutes; 
II. HIPEP group (n = 12) - peritoneal cavity of 
the rats was perfused with heated normal saline 
according to "Coliseum" (open) technique 
(parameters are described below). 
 
Animals 
The study was approved by the local ethics 
committee (REC No 3/297-20) and carried out 
in accordance with the European Convention 
for the Protection of Vertebrate Animals used 
for Experimental and Other Scientific 
Purposes: Appendix A of the ETS 123 and 
Directive 2010/63/EU on the protection of 
animals used for scientific purposes. Twenty 
four outbred female mature Wistar rats with 
median weight 294 g (min-max 274-381 g) 
were purchased from “Rappolovo” animal 
nursery (Leningrad Region, Russia). Rats were 
housed in polypropylene cages in a 
conventional facility (temperature 20–24°C, 
relative humidity 50–60%, 12 h light/12 h dark 
cycle). Animals received standard laboratory 
crop (Moscow, Russia) and tap water ad 
libitum.  
The ovarian cancer rat model 
The tumor strain was obtained as a result of 
transplacental carcinogenesis using high doses 
of 7,12-dimethylbenzanthracene (DMBA). The 
initial histological type of tumor is metastatic 
papillary adenocarcinoma, at present it is an 
ascitic tumor [13]. Tumor strain is maintained 
in female Wistar rats. On days 7-9 after IP 
inoculation, ascitic fluid was collected and 
transplanted IP to experimental animals (1×107 
cells in 0.5 ml of normal saline per rat). 
Open intraperitoneal perfusion technique 
Scheme of the experimental perfusion circuit is 
shown in Figure 1. Thirty minutes prior to and 
then twice a day on days 0-2 postoperatively, 
meloxicam («Renewal», Novosibirsk, Russia) 
was given subcutaneously 2 mg/kg for 
analgesia. Rats were anesthetized using 
isoflurane (Abbott Laboratories Limited, 
Queenborough, UK), 5% for induction and 2% 
for maintenance. No warming mattress was 
used during HIPEP, to avoid systemic 
hyperthermia. A midline laparotomy was 
performed with a 6-8 cm incision. A 
"Coliseum" was formed by hemming the edges 
of the abdominal wall with a surgical suture to 
a metal ring on a tripod. The inflow line was 
placed in the left subdiaphragmatic space and 
the outflow line in the right paracolic gutter. 
The parameters of the perfusion system were as 
follows: volume of perfusate (normal saline, 
"Slavyanskaya Apteka" LLC, Vladimir region, 
Russia) - 210 ml, flow rate - 30 ml/min, 
abdominal cavity temperature – 40.5-41.5 ℃ 
(for HIPEP group), perfusion time - 45 minutes. 
During perfusion the abdomen was massaged 
gently to achieve a uniform heat distribution. 
After completion of the perfusion, the 
abdominal wall was closed using 3/0 
polyglactin sutures for the muscular layer and 
3/0 non-absorbable polyester sutures for the 
skin. Additionally, the wound was strengthened  
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with BF-6 glue (JSC «Werteks», Saint-
Petersburg, Russia). Immediately after wound 
closure rats were given with 10 ml saline 
subcutaneously for rehydration. Cefepime (JSC 
«Sintez», Kurgan, Russia) 60 mg/kg was 
injected intramuscularly after perfusion and 
then for next 4 days once daily. The animal was 
placed on the absorbent sheet in a plastic cage. 
A heating platform (set at 40 ℃) was placed 
under the half of the cage in order to prevent 
hypothermia. To reduce stress, medium 
enrichment agents (minks) were placed into the 
cage. The first five days the postoperative 
wound was treated with Levomekol ointment 
(JSC "Nizhfarm", Nizhny Novgorod, Russia). 
Follow-up. The animals were observed 
throughout the entire period of their life. OS 
was defined as time from the day of tumor 
transplantation to day of animal death. The total 























and its grade of haemorrhagia were determined 
at autopsy. The total PCI was determined 
according to the modified method of Y.L. 
Klaver. et al. [14]. After laparotomy, the 
abdomen was carefully examined for tumor 
growth at eight different sites (see Table 1). The 
tumor load at each site was scored semi 
quantitatively: 0 – no macroscopic tumor; 1 – 
limited tumor growth (diameter 1–2 mm); 2 – 
moderate tumor growth (diameter 2–4 mm); 3 
– abundant (diameter more than 4 mm). In the 
case of multiple nodes in the organ, the node 
with the largest diameter was selected. The sum 
of scores from all sites represented the total PCI 
for that animal. The grade of ascites 
haemorrhagia was determined using a semi 
quantitative visual scale, where 0 - absence of 
hemorrhagic ascites; 1 - weak hemorrhagic 
ascites; 2- moderate hemorrhagic ascites; 3 - 
strong hemorrhagic ascites. Organs of the 
      
Figure 1. Scheme of the perfusion circuit for an experimental open NIPEP and HIPEP. 1 - position of the 
animal during the procedure: (A) – inflow line, (B) – outflow line, diameter 4 mm; 2 - perfusion roller pump 
(Russian State Scientific Center for Robotics and Technical Cybernetics, Saint-Petersburg, Russia); 3 - 
reservoir for perfusate; 4 - thermostatic water bath (Russian State Scientific Center for Robotics and Technical 
Cybernetics, Saint-Petersburg, Russia). 
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reproductive system of all animals, as well as 
organs and tissues with macroscopic signs of 
PC, were subjected to standard histological 
examination by light microscopy after 
hematoxylin and eosin staining. Cytological 
smears of ascites and pleural effusion were 
examined after Pappenheim's stain. 
 
Statistical Analysis 
Statistical analysis was performed using 
GraphPad Prism version 8.0. Based on pilot 
preclinical study (data was not published) 
required sample size was 12 animals per group 
to reject the null hypothesis that survival in the 
NIPEP group and the HIPEP group are equal 
with power (1-β)=80% and α=0.05 [15]. 
Nonparametric testing for the continuous data 
was performed using Mann-Whitney test. 
Comparison of categorical values was done 
using Fisher’s exact test. All tests were two-
sided; the level of statistical significance was 
set at a P value of <0.05. Survival outcomes 
were analyzed and expressed using Kaplan–
Meier curves and compared with the log-rank 
test. The Cox proportional-hazards model was 
used to obtain hazard ratio (HR) and its 95% 
confidence interval (95% CI). 
 
Results  
All animals in the NIPEP and HIPEP groups 
survived the procedure. On day 32 after HIPEP 
one of 12 rats died from infectious 
complications. Mean anesthesia time was 115 
minutes (min-max: 100-142). The dynamics of 
intraperitoneal and rectal temperature during 
HIPEP is shown in Figure 2. The set 
temperature in the abdominal cavity was 
reached 10-17 minutes after the installation of 
the lines and the start-up of the circuit. 
After IP transplantation tumor take rate 
achieved nearly 100% and led to haemorrhagic 
ascites formation and PC. Cancer-related 
mortality in rats was nearly 100%. The autopsy 
revealed tumor lesions in mesentery, greater 
omentum, parietal peritoneum and diaphragm. 
High volume tumor implants were observed in 
ovaries, horns and body of uterus, perigonadal 













Figure 2. The temperature course during HIPEP in 
















Figure 3. Macroscopic tumor view in rat with 
transplanted syngeneic ovarian carcinoma (NIPEP 
group). Tumor implants in mesentery, uterine horns 
and body with perigonadal fat pads, greater 
omentum and diaphragm. 
 
The development of peritoneal metastasis was 
accompanied by hemorrhagic ascites. In smears 
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of ascitic fluid extensive focuses of high-grade 
serous carcinoma discretely lying among the 
fields of cells of the monocytic series were 
determined. Cells were polymorphic, sharply 
atypical with large nuclei with nucleoli and a 




































It is noteworthy, that 3 out of 12 rats in the 
HIPEP group had haemorrhagic malignant 
pleural effusion (confirmed by cytologic 
examination) with involvement of organs in 
thoracic cavity (lungs, pericardium, 
intrathoracic lymph nodes). Macroscopically it 
was no evidence of tumor growth in the 
peritoneal cavity and ascites. 
Histological examination of autopsy material 
revealed invasive malignant tumor of a 
papillary-solid structure, consisting of rounded 
cells with scanty eosinophilic or optically 
empty cytoplasm, with large sharply atypical 
polymorphic nuclei, with a high nuclear-
cytoplasmic ratio (Figure 5). 
 
Kaplan–Meier’s curves are shown in Figure 6. 
Median OS was 19 days in the NIPEP group, 
























Figure 5. Microscopic tumor view. (A) – focus of serous high-grade carcinoma, haematoxylin and eosin, 
×400; (B) – tumor nodule on the parietal peritoneum, haematoxylin and eosin, ×60; (С) – invasion of the 
tumor into the body of the uterus and uterine horns, haematoxylin and eosin, ×5; (D) – a fragment of the 
greater omentum with tumor infiltration, haematoxylin and eosin, ×40. 
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difference in survival outcome was significant,  
log-rank test P=0.0013; HR=0.32 (95% CI 
0.13-0.82). One rat from the HIPEP group was 
sacrificed on day 138 after tumor 
transplantation without any signs of tumor 













Figure 6. Kaplan–Meier analysis of survival curves 
of rats with transplanted ovarian carcinoma. NIPEP 
– normothermic intraperitoneal perfusion with 
normal saline; HIPEP – hyperthermic 
intraperitoneal perfusion with normal saline. 
 
In NIPEP group all animals developed 
extensive intraperitoneal tumor growth at 
autopsy. Rats in the HIPEP group were found 
to have a significantly lower mean of the total 
PCI than rats in NIPEP group (P=0.00155). 
There was no significant difference in the 
ascites weight between groups owing to 
massive variation of this parameter. Although 
there was a trend towards a decrease in the 
HIPEP group. At the same time, ascites from 
HIPEP group had a more pronounced degree of 




The selective effects of hyperthermia on 
malignant cells as well as its ability to 
potentiate chemotherapy agents make it a 
valuable adjunct to intraperitoneal 
chemotherapy in the management of PC [16]. It 
is supported by an increasing number of 
research data. But available clinical data failed 
to isolate the antitumor effects of hyperthermia 
itself. Currently, the role of HIPEC in the 
management of primary and recurrent EOC is 
still not clear [17]. One of the reasons for this is 
insufficient experimental data, including 
preclinical studies on adequate experimental 
models. 
The chosen model of syngeneic ovarian 
carcinoma in Wistar rats resembles the clinical 
situation of advanced EOC (stage III-IV) in 
humans with the PC and ascites. The 
histological structure corresponded to the most 
common subtype of human ovarian tumor – 
high-grade serous carcinoma. The model 
resembles the microscopic disease before the 
emergence of visible nodules [18]. 
For our study we designed and tested a new 
peritoneal perfusion system in tumor bearing 
rats. We chose to use the “Coliseum” technique 
for NIPEP and HIPEP due to its advantages 
over the closed technique. It allows to achieve 
homogeneous temperature and better control of 
perfusate distribution within the peritoneal 
cavity, make the access to the entire cavity 
easier, prevents of bubble formation in the 
circuit and organ suction, possibility of 
debulking of large tumors before perfusion, 
easier circuit blockage corrections, and 
minimal risk of thermal damage of organs and 
tissues [12,19]. 
Here, we demonstrated that open HIPEP with 
saline only significantly increased the median 
survival of the animals from 19 to 39 days (log-
rank test P=0.0013) and reduced the risk of 
death by 68% (HR for HIPEP group vs NIPEP 
group 0.32; 95% CI 0.13-0.82). 
The exact mechanism of antitumor activity of 
hyperthermia is    not    fully    understood. It is  
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known that the cytotoxic effects of 
hyperthermia are caused by damage of cell 
membranes, nuclei, protein denaturation, and 
changes in the permeability to calcium ions. It 
disrupts mitotic processes of malignant and 
non-malignant cells too. In tumor cells, after 
exposure to hyperthermia, an increase in the 
number of lysosomes and the activity of 
lysosomal enzymes is established.  
Microcirculation in tumor tissue is suppressed 
by hyperthermia, which leads to decrease in 































whereas in normal tissues the blood flow 
increases. These effects, along with a violation 
of cellular respiration processes, lead to the 
accumulation of lactic acid and acidification of 
the tumor microenvironment, which leads to an 
increase in the number and "fragility" of 
lysosomes, accompanied by increased death of 
tumor cells [20]. 
Noteworthy is the profile of the OS curve in the 
HIPEP group. The presence of such "tails" may 
be associated with the activation of antitumor 
immunity in immunocompetent animals with 
Table 1. Influence of HIPEP with normal saline on the spread of transplanted ovarian carcinoma and 
the ascites weight on autopsy. 
 






Greater omentum 3 (3-3) 1 (0-3)  
Space between the liver and 
the diaphragm 
3 (0-3) 0 (0-3) 
 
Liver hilum 3 (0-3) 0 (0-3)  
Mesentery 3 (0-3) 0 (0-3)  
Diaphragm 0 (0-3) 0 (0-3)  
Ovaries 1 (0-3) 0 (0-2)  
Parietal peritoneum 0 (0-2) 0 (0-3)  
Uterine horns and body with 
perigonadal fat pads 
2,5 (0-3) 0 (0-3) 
 
Total PCIc 14 (2) 5 (2) 
Mann Whitney test, 
P=0.0155 





Mann Whitney test, 
P=0.1206 
Grade of ascites 
haemorrhagiab 
2 (2-2) 3 (2-3) 
Mann Whitney test, 
P=0.0379 
Intrathoracic tumor spread 
with malignant pleural 
effusion, n 
0 3 
Fisher's exact test, 
P=0.0932 
 
a Values are median (Q1-Q3) and c mean (SEM). b 3 animals with malignant pleural effusion and 1 
rat with infectious complications were excluded from PCI calculation.  
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transplanted syngeneic tumor. This profile 
resembles the OS curve of patients receiving 
checkpoint inhibitors with a long-term response 
to this therapy [21]. It is known that in addition 
to the direct cytotoxic effect on tumor cells, 
hyperthermia stimulates the production of heat 
shock proteins (HSPs) and their presentation in 
complex with the major histocompatibility 
complex class II, activates dendritic cells and 
natural killers, enhances the adhesive properties 
of T-cells and their traffic to peripheral tissues 
and promotes immune surveillance [22]. 
Locoregional intraperitoneal heating 
independently contributed to antitumor activity 
and reduced intraperitoneal tumor 
dissemination. In the HIPEP group the total PCI 
was significantly lower and a trend towards a 
decrease in the ascites weight was noticed. At 
the same time, ascites in animals from HIPEP 
group had a more pronounced degree of 
haemorrhagia. Probably, this was the main 
cause of death. An interesting observation from 
the study was that 3/12 rats in HIPEP group had 
haemorrhagic pleural effusion with malignant 
cells but without macroscopic evidence of 
tumor growth in peritoneal cavity and ascites. 
Such phenomenon may be due to tumor cells 
migration under conditions of high 
intraabdominal pressure and supranormal 
temperature during perfusion. 
Conclusions 
In conclusion, the model of syngeneic high-
grade ovarian carcinoma in Wistar rats and the 
original experimental perfusion circuit can be 
used for further investigation of HIPEC after 
proper equipment of the operating room by 
setting general and local ventilation, which will 
provide a special microclimate during the 
procedure. Our preclinical results 
supplemented the data about the antitumor 
activity of local hyperthermia and its role in the 
perfusion treatment of PC in ovarian tumors. 
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